Amy M. Barker

Amy M. Barker

Auto-generated profile, based on publicly available information

Amy M. Barker

Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Journal of Biological Physics
Verified
Journal Article
Open access
PDF file
Peter StockleyPeter Stockley
Peter Stockley
RTReidun Twarock
Reidun Twarock
SBSaskia E. Bakker
Saskia E. Bakker
ABAmy M. Barker
Amy M. Barker
ABAlexander Borodavka
Alexander Borodavka
RTRoman Tuma
Roman Tuma
The formation of a protective protein container is an essential step in the life-cycle of most viruses. In the case of single-stranded (ss)RNA viruses, this step occurs in parallel with genome packaging in a co-assembly process. Previously, it had been thought that this process can be explained entirely by electrostatics. Inspired by recent single-molecule fluorescence experiments that recapitulate the RNA packaging specificity seen in vivo for two model viruses, we present an alternative theory, which recognizes the important cooperative roles played by RNA–coat protein interactions, at sites we have termed packaging signals. The hypothesis is that multiple copies of packaging signals, repeated according to capsid symmetry, aid formation of the required capsid protein conformers at defined positions, resulting in significantly enhanced assembly efficiency. The precise mechanistic roles of packaging signal interactions may vary between viruses, as we have demonstrated for MS2 and STNV. We quantify the impact of packaging signals on capsid assembly efficiency using a dodecahedral model system, showing that heterogeneous affinity distributions of packaging signals for capsid protein out-compete those of homogeneous affinities. These insights pave the way to a new anti-viral therapy, reducing capsid assembly efficiency by targeting of the vital roles of the packaging signals, and opens up new avenues for the efficient construction of protein nanocontainers in bionanotechnology.

1 October 2011 in Journal of Molecular Biology
Verified
Journal Article
Closed access
DBDavid H.J. Bunka
David H.J. Bunka
SLStephen W. Lane
Stephen W. Lane
CLClaire L. Lane
Claire L. Lane
EDEric C. Dykeman
Eric C. Dykeman
RFRobert J. Ford
Robert J. Ford
Peter StockleyPeter Stockley
Peter Stockley

1 July 2013 in Structure
Verified
Journal Article
Open access
KDKyle C. Dent
Kyle C. Dent
RTRebecca Thompson
Rebecca Thompson
ABAmy M. Barker
Amy M. Barker
JHJulian Hiscox
Julian Hiscox
JBJohn Barr
John Barr
NRNeil Ranson
Neil Ranson
Simple, spherical RNA viruses have well-understood, symmetric protein capsids, but little structural information is available for their asymmetric components, such as minor proteins and their genomes, which are vital for infection. Here, we report an asymmetric structure of bacteriophage MS2, attached to its receptor, the F-pilus. Cryo-electron tomography and subtomographic averaging of such complexes result in a structure containing clear density for the packaged genome, implying that the conformation of the genome is the same in each virus particle. The data also suggest that the single-copy viral maturation protein breaks the symmetry of the capsid, occupying a position that would be filled by a coat protein dimer in an icosahedral shell. This capsomere can thus fulfill its known biological roles in receptor and genome binding and suggests an exit route for the genome during infection.

12 August 2013 in Hepatology
Verified
Journal Article
Open access
PDF file
Toshana FosterToshana Foster
Toshana Foster
GTGary S. Thompson
Gary S. Thompson
AKArnout P. Kalverda
Arnout P. Kalverda
JKJayakanth Kankanala
Jayakanth Kankanala
MBMatthew Bentham
Matthew Bentham
SGStephen Griffin
Stephen Griffin
Current interferon-based therapy for hepatitis C virus (HCV) infection is inadequate, prompting a shift toward combinations of direct-acting antivirals (DAA) with the first protease-targeted drugs licensed in 2012. Many compounds are in the pipeline yet primarily target only three viral proteins, namely, NS3/4A protease, NS5B polymerase, and NS5A. With concerns growing over resistance, broadening the repertoire for DAA targets is a major priority. Here we describe the complete structure of the HCV p7 protein as a monomeric hairpin, solved using a novel combination of chemical shift and nuclear Overhauser effect (NOE)-based methods. This represents atomic resolution information for a full-length virus-coded ion channel, or “viroporin,” whose essential functions represent a clinically proven class of antiviral target exploited previously for influenza A virus therapy. Specific drug-protein interactions validate an allosteric site on the channel periphery and its relevance is demonstrated by the selection of novel, structurally diverse inhibitory small molecules with nanomolar potency in culture. Hit compounds represent a 10,000-fold improvement over prototypes, suppress rimantadine resistance polymorphisms at submicromolar concentrations, and show activity against other HCV genotypes. Conclusion : This proof-of-principle that structure-guided design can lead to drug-like molecules affirms p7 as a much-needed new target in the burgeoning era of HCV DAA. (Hepatology 2014;59:408–422)

1 March 2013 in Journal of Molecular Biology
Verified
Journal Article
Open access
RFRobert J. Ford
Robert J. Ford
ABAmy M. Barker
Amy M. Barker
SBSaskia E. Bakker
Saskia E. Bakker
RCRobert H. Coutts
Robert H. Coutts
NRNeil Ranson
Neil Ranson
Peter StockleyPeter Stockley
Peter Stockley
We have examined the roles of RNA-coat protein (CP) interactions in the assembly of satellite tobacco necrosis virus (STNV). The viral genomic RNA encodes only the CP, which comprises a β-barrel domain connected to a positively charged N-terminal extension. In the previous crystal structures of this system, the first 11 residues of the protein are disordered. Using variants of an RNA aptamer sequence isolated against the CP, B3, we have studied the sequence specificity of RNA-induced assembly. B3 consists of a stem-loop presenting the tetra-loop sequence ACAA. There is a clear preference for RNAs encompassing this loop sequence, as measured by the yield of T=1 capsids, which is indifferent to sequences within the stem. The B3-containing virus-like particle has been crystallised and its structure was determined to 2.3Å. A lower-resolution map encompassing density for the RNA has also been calculated. The presence of B3 results in increased ordering of the N-terminal helices located at the particle 3-fold axes, which extend by roughly one and a half turns to encompass residues 8-11, including R8 and K9. Under assembly conditions, STNV CP in the absence of RNA is monomeric and does not self-assemble. These facts suggest that a plausible model for assembly initiation is the specific RNA-induced stabilisation of a trimeric capsomere. The basic nature of the helical extension suggests that electrostatic repulsion between CPs prevents assembly in the absence of RNA and that this barrier is overcome by correct placement of appropriately orientated helical RNA stems. Such a mechanism would be consistent with the data shown here for assembly with longer RNA fragments, including an STNV genome. The results are discussed in light of a first stage of assembly involving compaction of the genomic RNA driven by multiple RNA packaging signal-CP interactions.

2 January 2016 in Bacteriophage
Verified
Journal Article
Open access
Peter StockleyPeter Stockley
Peter Stockley
SWSimon J. White
Simon J. White
EDEric Dykeman
Eric Dykeman
IMIain Manfield
Iain Manfield
ÓRÓttar Rolfsson
Óttar Rolfsson
RTReidun Twarock
Reidun Twarock
Using RNA-coat protein crosslinking we have shown that the principal RNA recognition surface on the interior of infectious MS2 virions overlaps with the known peptides that bind the high affinity translational operator, TR, within the phage genome. The data also reveal the sequences of genomic fragments in contact with the coat protein shell. These show remarkable overlap with previous predictions based on the hypothesis that virion assembly is mediated by multiple sequences-specific contacts at RNA sites termed Packaging Signals (PSs). These PSs are variations on the TR stem-loop sequence and secondary structure. They act co-operatively to regulate the dominant assembly pathway and ensure cognate RNA encapsidation. In MS2, they also trigger conformational change in the dimeric capsomere creating the A/B quasi-conformer, 60 of which are needed to complete the T=3 capsid. This is the most compelling demonstration to date that this ssRNA virus, and by implications potentially very many of them, assemble via a PS-mediated assembly mechanism.